Treatment for an eye aneurysm depends on what type you have and whether it is causing active damage to your vision. The most common variety, a retinal arterial macroaneurysm, often resolves on its own without any intervention. When treatment is needed, options include laser therapy, injections of anti-VEGF medications into the eye, surgery to clear trapped blood, or some combination of these. A less common but more serious category involves aneurysms of the ophthalmic artery inside the skull, which require neurosurgical or endovascular procedures. The distinction matters because the word “eye aneurysm” gets used casually for conditions that sit in very different medical specialties.
Not All Eye Aneurysms Are the Same
When people say “eye aneurysm,” they usually mean one of three things. A retinal arterial macroaneurysm (RAM) is a bulge in one of the small arteries that supply the retina. These tend to show up in older adults, especially women with high blood pressure. A retinal microaneurysm is a much tinier ballooning of a capillary, most commonly seen in diabetic retinopathy. And an ophthalmic artery aneurysm is a bulge in the artery that feeds the eye from inside the skull, which falls under neurosurgery rather than ophthalmology. Each of these has its own treatment pathway, and conflating them leads to confusion.
Retinal macroaneurysms are the focus of most “eye aneurysm” searches, and the bulk of this article addresses them. Patients with macroaneurysms tend to have decreased visual acuity and a higher rate of hypertension than the general population, and retinal hemorrhage is present in roughly four out of five cases at diagnosis.1PubMed Central. Retinal arterial macroaneurysms: risk factors and natural history Diagnosis is typically made through a clinical exam combined with imaging such as optical coherence tomography (OCT) and dye-based angiography, which reveal both the aneurysm itself and any damage to the surrounding retina.2PubMed Central. Objective Assessment of Retinal Artery Macroaneurysm With Optical Coherence Tomography Angiography
When Observation Is the Right Call
The first thing to know is that most retinal macroaneurysms close up and heal without any medical procedure. The aneurysm thromboses on its own, the hemorrhage slowly clears, and vision recovers to a degree that varies with how much retinal damage occurred before the bleeding stopped. For aneurysms that are not threatening the macula (the central area of the retina responsible for sharp, detailed vision), observation with regular monitoring is standard practice.3EyeWiki. Macroaneurysm – Section: Management A retinal specialist will schedule follow-up imaging to confirm the aneurysm is shrinking rather than leaking further.
Co-management with a primary care physician is considered essential during the observation period, because controlling the underlying systemic condition, most commonly hypertension, influences how the aneurysm behaves.4PubMed Central. Ruptured retinal arterial macroaneurysm: diagnosis and management In at least one reported case, a retinal macroaneurysm that was the first sign of undiagnosed high blood pressure disappeared entirely once blood pressure was brought under control with medication.5PubMed. Retinal artery macroaneurysm as initial presentation of hypertension That does not mean every patient can skip eye-specific treatment, but it underscores that managing blood pressure is not just background care; it is part of the treatment itself.
Laser Photocoagulation
When a macroaneurysm is leaking fluid or blood into the macula and threatening central vision, laser treatment is one of the established interventions. The standard approach uses moderate-intensity laser applied in two to three rows of large spots immediately around the aneurysm. The goal is to seal the leaking vessel and limit further fluid accumulation in the retina.3EyeWiki. Macroaneurysm – Section: Management
A study comparing conventional laser photocoagulation with a newer navigated laser system found that both approaches led to meaningful improvements in visual acuity and reductions in retinal thickness, with no treatment-related adverse effects over about eleven months of follow-up. The navigated system used roughly half the total laser energy per session, which could translate to less collateral thermal damage, though the visual outcomes were similar between the two groups.6PubMed Central. Direct navigated laser photocoagulation as primary treatment for retinal arterial macroaneurysms
Laser treatment does carry a trade-off. In one study of retinal macroaneurysms, the artery downstream of the aneurysm occluded after laser in about one in six patients, compared with spontaneous occlusion in fewer than one in ten.1PubMed Central. Retinal arterial macroaneurysms: risk factors and natural history That does not always cause noticeable vision loss, but it is one reason laser is typically reserved for cases where the macula is genuinely at risk rather than used as a blanket preventive measure.
Anti-VEGF Injections
Anti-VEGF drugs, injected directly into the eye, have become a major treatment option for macroaneurysms that cause macular edema or significant hemorrhage. These medications block a protein called vascular endothelial growth factor that drives abnormal blood vessel leakage. The agents used include bevacizumab, ranibizumab, and aflibercept, all of which are widely used for other retinal conditions like age-related macular degeneration and diabetic eye disease.
A comparative study found that patients treated with anti-VEGF injections actually started out with worse vision than those treated with laser, yet achieved greater improvements in both visual acuity and retinal thickness.7PubMed Central. Observation, laser photocoagulation or anti-VEGF therapy in the management of retinal arterial macroaneurysms In a case series evaluating 38 eyes, anti-VEGF treatment reduced macular edema and hard exudates in every case.3EyeWiki. Macroaneurysm – Section: Management A separate two-case report described macroaneurysms transforming into inactive white fibrous masses after anti-VEGF injections, with the leakiness of the vessel wall halting entirely.8PubMed Central. The Management of Two Cases with Retinal Arterial Macroaneurysm by Anti-Vascular Endothelial Growth Factor
The evidence here is promising but still evolving. Most of the data comes from retrospective studies and case series rather than large randomized controlled trials. The consistent finding, though, is that anti-VEGF therapy works at least as well as laser for reducing fluid and improving vision, with some data suggesting it may work better in the patients who need it most.
Combination Therapy
Some retinal specialists are using laser and anti-VEGF together, particularly in hemorrhagic cases. A study comparing laser alone, anti-VEGF alone, combination therapy, and observation in hemorrhagic macroaneurysms found that all three active treatment groups saw significant visual improvement, while the observation group did not. Combining the two approaches had a practical advantage: it reduced the total number of anti-VEGF injections needed.9PubMed Central. Retinal laser photocoagulation and intravitreal injection of anti-VEGF for hemorrhagic retinal arterial microaneurysm
Another study of exudative macroaneurysms found that laser alone sometimes left residual fluid at the one-month mark, while adding a single anti-VEGF injection to laser treatment produced a dry macula and visual gains more quickly.10Asia-Pacific Journal of Ophthalmology. Laser and Anti-Vascular Endothelial Growth Factor Agent Treatments for Retinal Arterial Macroaneurysms The combination approach is especially appealing for patients who want faster resolution or who have both leaking and bleeding going on at once.
Surgical Procedures for Severe Bleeding
When a macroaneurysm ruptures badly enough to trap a large pool of blood underneath the macula (a submacular hemorrhage), the stakes rise. Blood sitting under the retina is toxic to the photoreceptor cells, and the longer it stays there, the more permanent damage it causes. In these situations, the goal shifts from sealing a leaking vessel to physically moving or dissolving the blood clot.
One option is pneumatic displacement: a gas bubble is injected into the eye and the patient is positioned face-down so that the bubble pushes the blood away from the macula. A study of twelve patients (three of whom had macroaneurysms) used this technique with an injection performed within 24 hours of presentation.11PubMed Central. Pneumatic displacement of submacular haemorrhage Sometimes a clot-dissolving drug called tissue plasminogen activator (tPA) is injected beneath the retina first to break up the clot before the gas bubble displaces it.
For more extensive hemorrhages, a vitrectomy may be performed. This is actual surgery: the vitreous gel inside the eye is removed, tPA is injected under the retina, and a gas or air bubble is placed to push the loosened blood aside. A study evaluating this approach in both macroaneurysm and age-related macular degeneration patients concluded that it was effective at displacing the blood, but that the final visual outcome depended heavily on whatever underlying damage had already occurred in the macula.12PubMed Central. Visual Outcome after Vitrectomy with Subretinal tPA Injection to Treat Submacular Hemorrhage Secondary to Age-Related Macular Degeneration or Macroaneurysm
Surgery carries its own risks. A study examining vitrectomy for submacular hemorrhage in macroaneurysm patients found that macular holes developed in roughly one in five eyes. Among those who received subretinal tPA, the rate was even higher. The macular holes were typically identified during surgery and repaired in the same procedure, but the complication underscores that these operations are not trivial.13PubMed Central. Incidence of macular hole in patients undergoing pars plana vitrectomy for submacular hemorrhage
A less invasive option for blood trapped in front of the retina (premacular hemorrhage rather than submacular) is a YAG laser procedure that punctures the membrane holding the blood in place, allowing it to drain into the vitreous cavity where it clears on its own over time.3EyeWiki. Macroaneurysm – Section: Management
Factors That Affect Visual Recovery
Not everyone who gets treated ends up with the same outcome. Two factors that strongly predict worse final vision after a ruptured macroaneurysm are bleeding within the retinal layers (intraretinal hemorrhage) and the development of a macular hole. A study quantifying this found that patients without either complication recovered to roughly 20/30 vision on average, while patients with intraretinal hemorrhage, with or without a macular hole, ended up closer to 20/150.14PubMed. Impact of Macular Intraretinal Hemorrhage and Macular Hole on the Visual Prognosis of Submacular Hemorrhage Due to Retinal Arterial Macroaneurysm Rupture The message is that how much damage occurs before treatment begins matters at least as much as which treatment is chosen.
Speed of intervention plays a role in the surgical cases especially. When blood is sitting under the macula, earlier displacement generally leads to better outcomes. Patients who present weeks after a bleed have already sustained photoreceptor damage that no surgery can reverse. This is one area where the “wait and see” philosophy that works for uncomplicated macroaneurysms can backfire if applied to cases with large submacular hemorrhages.
Ophthalmic Artery Aneurysms Near the Brain
The other kind of “eye aneurysm” lives not inside the eye itself but on the ophthalmic artery where it branches off the internal carotid artery inside the skull. These are intracranial aneurysms that happen to press on or compromise blood flow to the eye. They can cause visual field deficits, double vision, or sudden vision loss if they rupture. Treatment here is entirely different from retinal macroaneurysm care and falls under neurosurgery or interventional neuroradiology.
Two main options exist: microsurgical clipping, where a neurosurgeon opens the skull and places a clip across the neck of the aneurysm, and endovascular coiling, where a catheter threaded through the blood vessels delivers tiny coils into the aneurysm to block blood flow. A study comparing the two in ophthalmic artery aneurysms found that both achieved similar rates of aneurysm closure, but coiling caused far fewer visual complications. Post-treatment visual deficits occurred in about 2% of coiled patients versus roughly 16% of clipped patients.15PubMed Central. Comparison of Visual Outcomes of Ophthalmic Artery Aneurysms Treated with Microsurgical Clipping and Endovascular Coiling
A newer approach, flow diversion, uses a mesh stent placed inside the parent artery to redirect blood flow away from the aneurysm, which gradually clots off. A meta-analysis of paraclinoid aneurysms (a category that includes ophthalmic artery aneurysms) found that vision improved in about 71% of patients treated with flow diversion, compared with 58% after clipping and 49% after coiling. Vision worsened in only about 5% of flow-diversion patients.16Neurosurgical Focus. Vision outcomes in patients with paraclinoid aneurysms treated with clipping, coiling, or flow diversion: a systematic review and meta-analysis Flow diversion is relatively new, and the follow-up periods in available studies are shorter than for the other two methods, so the long-term picture is still filling in.
For patients whose vision was already compromised before treatment, endovascular coiling of ophthalmic segment aneurysms improved visual symptoms in roughly two-thirds of cases, with only about 9% experiencing a decline. Patients who already had optic nerve atrophy at the time of treatment were least likely to improve.17American Journal of Neuroradiology. Vision Outcomes and Major Complications after Endovascular Coil Embolization of Ophthalmic Segment Aneurysms
Blood Pressure and Systemic Health
High blood pressure is the single most consistent risk factor for retinal arterial macroaneurysms. Hypertension weakens arterial walls over years, and the small arteries of the retina are particularly vulnerable because they lack the structural reinforcement that larger arteries have. Getting blood pressure under control is not just helpful; it directly affects whether a macroaneurysm heals, stays stable, or ruptures.
This is why retinal specialists emphasize co-management with the patient’s primary care doctor or cardiologist. Even when the eye is being treated with laser or injections, uncontrolled blood pressure undermines those treatments. If you are diagnosed with a retinal macroaneurysm and have never been evaluated for hypertension, that evaluation should happen promptly, because in some patients the eye problem is the first visible sign of a systemic cardiovascular issue.5PubMed. Retinal artery macroaneurysm as initial presentation of hypertension
Preventive Laser and the Debate Around It
An unsettled question is whether macroaneurysms that have not yet ruptured but look like they might should be treated preemptively with laser. The case for it is straightforward: a rupture can cause rapid, severe vision loss from hemorrhage, and sealing the aneurysm before that happens could spare the patient a worse outcome. One group of researchers explicitly argued that preventive photocoagulation should be considered for macroaneurysms with associated retinal hemorrhage, given how quickly vision can deteriorate when rupture occurs.18PubMed Central. Need of preventive photocoagulation for retinal arterial macroaneurysm with retinal hemorrhage
The case against routine preventive treatment is that most macroaneurysms close up on their own, and laser carries the risk of downstream arteriolar occlusion. Treating every macroaneurysm preemptively means exposing many patients to procedure risk when their aneurysm would have resolved without intervention. There is no large trial settling this debate, so the decision typically comes down to the individual patient’s risk profile and the retinal specialist’s judgment.
Advances in Detection and Monitoring
Better imaging is changing how these conditions are managed. Optical coherence tomography angiography (OCTA) produces three-dimensional maps of retinal blood flow without injecting any dye, making it easier to spot aneurysms and track their response to treatment over time. Artificial intelligence applied to OCTA images is pushing the detection of subtle vascular abnormalities, including microaneurysms in diabetic retinopathy, further than what a human reader can achieve alone.19PubMed Central. Artificial intelligence in OCT angiography A recent method combining blood-flow signals with structural OCT data and three-dimensional reconstruction improved the detection of microaneurysms that were difficult to spot with OCTA alone.20PubMed. A novel OCTA-based image processing method for enhanced microaneurysm detection and 3D visualization in diabetic retinopathy
For patients, the practical takeaway from these advances is that monitoring is becoming less invasive and more precise. Conditions that once required repeated dye injections to track can now be followed with non-invasive scans, making it more feasible to catch changes early and act before significant damage accumulates. That shift toward earlier detection and lighter-touch monitoring may eventually change the treatment landscape too, by identifying aneurysms at a stage where a single injection or a brief laser session can resolve the problem before it becomes surgical.